Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
STLE Annual MeetingSTLE Annual Meeting
Not Confirmed
Not Confirmed
18-22 May, 2025
Not Confirmed
Not Confirmed
19-22 May, 2025
Not Confirmed
Not Confirmed
20-22 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
STLE Annual MeetingSTLE Annual Meeting
Industry Trade Show
Not Confirmed
18-22 May, 2025
Industry Trade Show
Not Confirmed
19-22 May, 2025
Industry Trade Show
Not Confirmed
20-22 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions
30 Jun 2023
// Amber Tong ENDPTS
https://endpts.com/bellerophon-therapeutics-lets-almost-all-employees-go-looks-for-deals-in-wake-of-phiii-flop/
06 Jun 2023
// CLINICAL TRIALS ARENA
https://www.clinicaltrialsarena.com/news/bellerophon-therapeutics-fild-trial/
05 Jun 2023
// Amber Tong ENDPTS
https://endpts.com/bellerophon-therapeutics-drug-device-fails-another-phiii-in-lung-disease-stock-implodes/
05 Jun 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/06/05/2681822/0/en/Bellerophon-Announces-Top-Line-Data-from-Phase-3-REBUILD-Clinical-Trial-of-INOpulse-for-Treatment-of-Fibrotic-Interstitial-Lung-Disease.html
15 May 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/05/15/2669391/0/en/Bellerophon-Provides-Clinical-Program-Update-and-Reports-First-Quarter-2023-Financial-Results.html
11 May 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/05/11/2666738/0/en/Bellerophon-Therapeutics-Announces-Last-Patient-Has-Completed-Blinded-Treatment-in-Phase-3-REBUILD-Study-for-INOpulse-in-Fibrotic-Interstitial-Lung-Disease.html
ABOUT THIS PAGE